152 related articles for article (PubMed ID: 33177111)
21. ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Garnham R; Geh D; Nelson R; Ramon-Gil E; Wilson L; Schmidt EN; Walker L; Adamson B; Buskin A; Hepburn AC; Hodgson K; Kendall H; Frame FM; Maitland N; Coffey K; Strand DW; Robson CN; Elliott DJ; Heer R; Macauley M; Munkley J; Gaughan L; Leslie J; Scott E
Commun Biol; 2024 Mar; 7(1):276. PubMed ID: 38448753
[TBL] [Abstract][Full Text] [Related]
22. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4.
Ma X; Dong W; Su Z; Zhao L; Miao Y; Li N; Zhou H; Jia L
Cell Death Dis; 2016 Dec; 7(12):e2561. PubMed ID: 28032858
[TBL] [Abstract][Full Text] [Related]
23. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
Dalziel M; Whitehouse C; McFarlane I; Brockhausen I; Gschmeissner S; Schwientek T; Clausen H; Burchell JM; Taylor-Papadimitriou J
J Biol Chem; 2001 Apr; 276(14):11007-15. PubMed ID: 11118434
[TBL] [Abstract][Full Text] [Related]
24. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
[TBL] [Abstract][Full Text] [Related]
25. Study of O-glycan sialylation in C6 cultured glioma cells: evidence for post-translational regulation of a beta-galactoside alpha 2,3 sialyltransferase activity by N-glycosylation.
Broquet P; George P; Geoffroy J; Reboul P; Louisot P
Biochem Biophys Res Commun; 1991 Aug; 178(3):1437-43. PubMed ID: 1872858
[TBL] [Abstract][Full Text] [Related]
26. Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis.
Dall'Olio F; Mariani E; Tarozzi A; Meneghetti A; Chiricolo M; Lau JT; Facchini A
Glycobiology; 1997 Jun; 7(4):507-13. PubMed ID: 9184831
[TBL] [Abstract][Full Text] [Related]
27. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
[TBL] [Abstract][Full Text] [Related]
28. Integrated
Agrawal P; Chen S; de Pablos A; Jame-Chenarboo F; Miera Saenz de Vega E; Darvishian F; Osman I; Lujambio A; Mahal LK; Hernando E
bioRxiv; 2024 Mar; ():. PubMed ID: 38559078
[TBL] [Abstract][Full Text] [Related]
29. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
[TBL] [Abstract][Full Text] [Related]
30. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid.
Gross HJ; Merling A; Moldenhauer G; Schwartz-Albiez R
Blood; 1996 Jun; 87(12):5113-26. PubMed ID: 8652824
[TBL] [Abstract][Full Text] [Related]
31. The expression and functional analysis of the sialyl-T antigen in prostate cancer.
Bai R; Luan X; Zhang Y; Robbe-Masselot C; Brockhausen I; Gao Y
Glycoconj J; 2020 Aug; 37(4):423-433. PubMed ID: 32583304
[TBL] [Abstract][Full Text] [Related]
32. Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.
Sotiropoulou G; Kono M; Anisowicz A; Stenman G; Tsuji S; Sager R
Mol Med; 2002 Jan; 8(1):42-55. PubMed ID: 11984005
[TBL] [Abstract][Full Text] [Related]
33. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikis.
Su ML; Chang TM; Chiang CH; Chang HC; Hou MF; Li WS; Hung WC
PLoS One; 2014; 9(6):e98823. PubMed ID: 24915301
[TBL] [Abstract][Full Text] [Related]
35. Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancer.
van der Haar Àvila I; Zhang T; Lorrain V; de Bruin F; Spreij T; Nakayama H; Iwabuchi K; García-Vallejo JJ; Wuhrer M; van Kooyk Y; van Vliet SJ
Glycobiology; 2024 May; 34(7):. PubMed ID: 38785323
[TBL] [Abstract][Full Text] [Related]
36. "Aberrant sialylation plays a significant role in oral squamous cell carcinoma progression".
Mehta KA; Patel KA; Pandya SJ; Patel PS
J Oral Pathol Med; 2020 Mar; 49(3):253-259. PubMed ID: 31747460
[TBL] [Abstract][Full Text] [Related]
37. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis.
Priatel JJ; Chui D; Hiraoka N; Simmons CJ; Richardson KB; Page DM; Fukuda M; Varki NM; Marth JD
Immunity; 2000 Mar; 12(3):273-83. PubMed ID: 10755614
[TBL] [Abstract][Full Text] [Related]
38. Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.
Kwon YC; Kim H; Meyer K; Di Bisceglie AM; Ray R
J Immunol; 2016 Aug; 197(4):1127-36. PubMed ID: 27357152
[TBL] [Abstract][Full Text] [Related]
39. Lectin binding assays for in-process monitoring of sialylation in protein production.
Xu W; Chen J; Yamasaki G; Murphy JE; Mei B
Mol Biotechnol; 2010 Jul; 45(3):248-56. PubMed ID: 20379804
[TBL] [Abstract][Full Text] [Related]
40. Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.
Lee A; Chick JM; Kolarich D; Haynes PA; Robertson GR; Tsoli M; Jankova L; Clarke SJ; Packer NH; Baker MS
Mol Cell Proteomics; 2011 Sep; 10(9):M900538MCP200. PubMed ID: 20167946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
